Tang Kevin C's Form 4 filing
TCR2 Therapeutics Inc. (TCRR) · filed May 5, 2023
- Accession no.
- 0001209191-23-027833
- Filed
- May 5, 2023, 6:52 PM ET
- Trade date
- May 3-5, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $547.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tang Kevin CCIK 0001178579 | 10% Owner |
| Tang Capital Partners LPCIK 0001191935 | 10% Owner |
| Tang Capital Management LLCCIK 0001232621 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 3, 2023 | Common Stock | PPurchaseAcquired | +18,513 | $1.85 | +$34,249.05 | 3,944,800 | Indirect | |
| May 4, 2023 | Common Stock | PPurchaseAcquired | +104,241 | $1.86 | +$193,888.26 | 4,049,041 | Indirect | |
| May 5, 2023 | Common Stock | PPurchaseAcquired | +95,759 | $1.90 | +$181,942.1 | 4,144,800 | Indirect | |
| May 5, 2023 | Common Stock | PPurchaseAcquired | +71,064 | $1.94 | +$137,864.16 | 4,215,864 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.